Literature DB >> 16330556

Auger electrons: lethal, low energy, and coming soon to a tumor cell nucleus near you.

C Andrew Boswell1, Martin W Brechbiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330556

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  15 in total

1.  Computational modeling of cellular effects post-irradiation with low- and high-let particles and different absorbed doses.

Authors:  Adriana Alexandre S Tavares; João Manuel R S Tavares
Journal:  Dose Response       Date:  2012-03-19       Impact factor: 2.658

2.  Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.

Authors:  Jürgen Grünberg; Dennis Lindenblatt; Holger Dorrer; Susan Cohrs; Konstantin Zhernosekov; Ulli Köster; Andreas Türler; Eliane Fischer; Roger Schibli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-24       Impact factor: 9.236

Review 3.  Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

Authors:  C Andrew Boswell; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2007-06-08       Impact factor: 2.408

4.  Surface-engineered nanomaterials as X-ray absorbing adjuvant agents for Auger-mediated chemo-radiation.

Authors:  Sang-Min Lee; De-Hao Tsai; Vincent A Hackley; Martin W Brechbiel; Robert F Cook
Journal:  Nanoscale       Date:  2013-06-21       Impact factor: 7.790

Review 5.  Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Michael R Zalutsky; Alexander S Sobolev
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer.

Authors:  Yunjun Guo; Jesse J Parry; Richard Laforest; Buck E Rogers; Carolyn J Anderson
Journal:  J Nucl Med       Date:  2013-07-19       Impact factor: 10.057

7.  Methodology for labeling proteins and peptides with lead-212 (212Pb).

Authors:  Kwamena E Baidoo; Diane E Milenic; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2013-04-17       Impact factor: 2.408

Review 8.  Imaging for Response Assessment in Cancer Clinical Trials.

Authors:  Anna G Sorace; Asser A Elkassem; Samuel J Galgano; Suzanne E Lapi; Benjamin M Larimer; Savannah C Partridge; C Chad Quarles; Kirsten Reeves; Tiara S Napier; Patrick N Song; Thomas E Yankeelov; Stefanie Woodard; Andrew D Smith
Journal:  Semin Nucl Med       Date:  2020-06-10       Impact factor: 4.446

Review 9.  Auger processes in the 21st century.

Authors:  Roger W Howell
Journal:  Int J Radiat Biol       Date:  2008-12       Impact factor: 2.694

10.  Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues.

Authors:  Charles Zhu; Amey Bandekar; Michelle Sempkowski; Sangeeta Ray Banerjee; Martin G Pomper; Frank Bruchertseifer; Alfred Morgenstern; Stavroula Sofou
Journal:  Mol Cancer Ther       Date:  2015-11-19       Impact factor: 6.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.